Introduction
============

Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency disorder syndrome (AIDS) has shown a rapid increasing trend \[[@B1]\]. This problem is closely associated to injecting drug users (IDUs) in Iran, accounting for 67% of HIV positive cases and 85% of AIDS cases \[[@B2]\].

HIV studies in Iran have underscored the sharing injecting equipments as the main routes of transmission \[[@B3]\]. In one study, lifetime and last time needle and syringe sharing was reported by 50% and 25% of IDUs, respectively \[[@B4]\]. In another study, in a drug treatment sample, more than two-thirds of the IDUs had shared syringes \[[@B5]\].

Identifying factors associated with needle and syringe sharing among IDUs is particularly important for HIV prevention \[[@B6]\]. While very little is known about associated factors of needle and syringe sharing among Iranian IDUs \[[@B7]-[@B9]\], we here aimed to determine the prevalence and associates of needle and syringe sharing among a sample of IDUs in Iran.

Methods
=======

Design and setting
------------------

This is a secondary analysis of a cross-sectional survey on 7,743 individuals as a rapid situation assessment (RSA) performed by the Darius institute. Grant was awarded by the Iranian Research Center for Substance Use and Dependence (DARIUS Institute) affiliated to the University of Social Welfare and Rehabilitation Sciences. The study was approved by the ethical review committee of the university and informed consent was obtained from all the participants after they had been verbally reassured that the information would be kept confidential, especially from correctional system. This study was conducted under the financial aid of the Drugs Control Headquarters (DCHQ). Some other manuscripts have been extracted from this database.

Samples and sampling
--------------------

The participants were substance dependent persons according to DSM-IV and sampled from treatment centers (n = 1,217), prisons (n = 584) and streets (n = 5,860) of the capitals of 29 provinces in the Islamic Republic of Iran. The samples from treatment centers were selected at random from newcomers. Prisons sampling was also carried out randomly among those who were registered into the prison within previous 30 days. Snowball approach was used to take sample from streets. The number of samples taken from every province was proportional to the whole population of the province. The sampling started in April 2007 and lasted for 5 months. This sampling method is used as the main sampling strategy of drug use in DCHQ studies.

Process
-------

The interviews were carried out by university graduates (MS, BS) with drug abuse related majors/degrees who were dispatched to the provinces after being trained through workshops in Tehran (the capital of Islamic Republic of Iran). Each interview took 1 to 1 and a half hour. Data were collected using paper-based questionnaire namely Inventory for Drug Dependency-IV, which was the modified version of the one used in the previous national RSA of Iran performed by the research center \[[@B10]\]. The revision was done through a series of expert panel meetings, and new items and questions were added that met the desired objectives. Sixty nine items were classified in 9 different parts including: 1) socioeconomic data (at the time of data collection), 2) family data, 3) first use data, 4) lifetime drug use, 5) current drug of dependency, 6) injection data, 7) high risk behavior, 8) treatment data, and 9) social network.

Independent data
----------------

Data included in this study included the following parts:

I\) socio-demographic data: Data consisted age, age of beginning addiction, age of beginning injection, duration of injection, gender, educational level, marital status, living place, status of home, status of employment, alone living, income, legal income, illegal income, drug sell income, monthly family income, cigarette smoking, family history of cigarette smoking, family history of drug use

II\) Drug related data consisted monthly money that IDUs used for dominant substance, first place of drug use, first situation of drug use, most reason for first drug use, first pesrson that who suggested drug use, dominant drug that current injectors was used(type of drug), poly drug use and history of drug problems treatment.

III\) Injection related data consisted first place of injection, situation of first injection, cause of first injection, frequency of injection in the past years, usual place of injection and alone injection.

IV\) Non-sexual high risk behaviors consisted of history of arrest, and history of imprisonment.

To make the final costs internationally comparable, the costs which were registered in Iranian Rials were converted to purchase power parity or international Dollar (PPP\$). The conversion rate for PPP\$ was based on a recently published Iranian study, which had reached at an estimation of PPP\$ equal to 2727 Rials according to the information from the Central Bank of Iran and the World Bank database \[[@B11]\].

Outcome
-------

Lifetime needle and syringe sharing was defined as borrowing or lending syringe, needle or other injection equipments at least once in their life \[[@B12]-[@B14]\]. The most important cause for needle and syringe sharing was also included, with a multiple choice question. Answers included \"no access to sterile syringes\", \"to get more pleasure\", \"quick injection\", \"being sure at the shared syring\", \"financial limitations\", \"not aware of possible risk\", \"easy injection\" and \"peer pressure\" \[[@B15]-[@B17]\].

Statistical analysis
--------------------

The data obtained in the SPSS for Windows 13 statistical package. In order to present quantitative data, median (percentile 25% = Q1 and percentile 75% = Q3), mean and standard deviation was used. In order to compare the qualitative variables between those with and without \"needle and syringe sharing\", chi-square test was used. The comparison of age between two groups was done with t-test and expenditures of drug use between two groups with Mann-Whitney. Multivariate stepwise logistic regression was used to determine the predictors of lifetime syring sharing. P value \< 0.05 was considered significant.

Results
=======

Mean age at study, age at first drug use, age at first injection, and duration of injection of the participants were 31.3 ± 8.3, 18.6 ± 5.4, 25.9 ± 6.7 and 7.4 ± 6.3, respectively. Most participants were Muslim, lived in urban area, single, with a lower diploma educational level.

Needle and syringe sharing
--------------------------

From all 2091 IDUs, 749(35.8%) reported lifetime experience of needle and syringe sharing. Most frequent causes for needle and syringe sharing included \"no access to sterile syringes\" (n = 437; 20.9%), \"to get more pleasure\" (n = 274; 13.1%), \"quick injection\" (n = 164; 7.8%), \"being sure at the shared syring\" (n = 128; 6.1%), \"financial limitations\" (n = 128; 6.1%), \"not aware of possible risk\" (n = 99; 4.7%), \"easy injection\" (n = 94; 4.5%) and \"peer pressure\" (n = 61; 2.9%).

Associates of Needle and syringe sharing
----------------------------------------

### Socio-demographic data

IDUs with lifetime syring sharing had a higher mean age (32.3 ± 8.9 vs. 31.4 ± 8.1; p = 0.02), lower age of first drug use (17.9 ± 5 vs. 18.6 ± 5.4; p = 0.005), higher duration of injection (6.5 ± 6.3 vs. 5.4 ± 5.5; p \< 0.001). Age at first injection was not linked to lifetime syring sharing (25.8 ± 6.8 vs. 26.1 ± 6.7; p = 0.28). IDUs with lifetime syring sharing had lower monthly family income (733 ppp\$, Q1 = 330 ppp\$, Q3 = 1283 ppp\$ vs. 807 ppp\$, Q1 = 476 ppp\$, Q3 = 1466 ppp\$; p \< 0.001). Overall monthly paiment on drugs were not linked to lifetime syring sharing (586 ppp\$, Q1 = 330 ppp\$, Q3 = 1063 ppp\$ vs. 550 ppp\$, Q1 = 366 ppp\$, Q3 = 1100 ppp\$; p = 0.44). Bivariate analysis showed that needle and syringe sharing was significantly higher in females, those who lived in rural area, those who were illiterate, those who were separate/divorce/widow, homeless, those who lived alone, those jobless, those with illegal income, those with drug related income and those with drug use family members (Table [1](#T1){ref-type="table"}).

###### 

The comparison of syringe sharing between socio-demographic variables

                                                                                                        Syringe sharing           
  -------------------------------------------------- -------------------------------------------------- ----------------- ------- ---------
  **Sex**                                            Male                                               713               35.4%   0.029
                                                                                                                                  
                                                     Female                                             35                47.9%   
                                                                                                                                  
  **Religious type**                                 Muslim                                             737               36.0%   0.164
                                                                                                                                  
                                                     other                                              2                 16.7%   
                                                                                                                                  
  **Living place**                                   Urban                                              640               35.0%   0.004
                                                                                                                                  
                                                     Rural                                              62                47.7%   
                                                                                                                                  
  **Education level**                                Illiterate or were barely able to read and write   94                43.7%   0.002
                                                                                                                                  
                                                     Under diploma                                      607               36.0%   
                                                                                                                                  
                                                     Upper diploma                                      35                25.0%   
                                                                                                                                  
  **Marital status**                                 single                                             421               38.0%   \<0.001
                                                                                                                                  
                                                     Married                                            166               26.4%   
                                                                                                                                  
                                                     Separate, divorce and widow                        153               46.8%   
                                                                                                                                  
  **Status of home**                                 Having home                                        575               32.4%   0.000
                                                                                                                                  
                                                     Homeless                                           144               62.1    
                                                                                                                                  
  **Alone Living**                                   No                                                 567               32.8%   \<0.001
                                                                                                                                  
                                                     Yes                                                182               50.6%   
                                                                                                                                  
  **Occupation**                                     No                                                 353               28.5%   \<0.001
                                                                                                                                  
                                                     Yes                                                396               46.5%   
                                                                                                                                  
  **Boss type**                                      State                                              13                25.0%   0.591
                                                                                                                                  
                                                     Private                                            114               30.9%   
                                                                                                                                  
                                                     khisfarrma                                         126               28.5%   
                                                                                                                                  
  **Drug Income**                                    No                                                 462               30.2%   \<0.001
                                                                                                                                  
                                                     Yes                                                267               52.0%   
                                                                                                                                  
  **Job Income**                                     No                                                 409               43.1%   \<0.001
                                                                                                                                  
                                                     Yes                                                320               29.3%   
                                                                                                                                  
  **Illegal Income**                                 No                                                 412               28.5%   \<0.001
                                                                                                                                  
                                                     Yes                                                317               53.0%   
                                                                                                                                  
  **Legal Non Job Income**                           No                                                 345               35.3%   0.775
                                                                                                                                  
                                                     Yes                                                384               36.0%   
                                                                                                                                  
  **Furniture sell Income**                          No                                                 683               35.5%   0.483
                                                                                                                                  
                                                     Yes                                                46                38.7%   
                                                                                                                                  
  **Lifetime smoking**                               Never smoking                                      23                34.3%   0.636
                                                                                                                                  
                                                     Current smoking                                    690               36.1%   
                                                                                                                                  
                                                     Past smoking                                       36                31.9%   
                                                                                                                                  
  **cigarette smoking by parents**                   No                                                 296               29.8%   \<0.001
                                                                                                                                  
                                                     Yes                                                453               41.3%   
                                                                                                                                  
  **cigarette smoking by other members of family**   No                                                 178               26.8%   \<0.001
                                                                                                                                  
                                                     Yes                                                571               40.0%   
                                                                                                                                  
  **Substance use by parents**                       No                                                 475               31.3%   \<0.001
                                                                                                                                  
                                                     Yes                                                274               47.7%   
                                                                                                                                  
  **Substance use by members of family**             No                                                 337               29.0%   \<0.001
                                                                                                                                  
                                                     Yes                                                412               44.3%   

### Substance-related and injection-related data

Needle and syringe sharing was higher in IDUs who used heroin (331,41.3% vs. 418,32.4%; p \< 0.001), was lower in those who used opioium (47,23.6% vs.702,37.1%; p \< 0.001) and was lower in those who used Amphetamines (12,15.6% vs. 737,36.6%; p \<0.001). Poly drug users was associated with needle and syringe sharing (321, 40.5% vs. 415, 33.3%; p = 0.001). (Table [2](#T2){ref-type="table"}).

###### 

The comparison of syringe sharing between drug use-related variables

                                                                                                                                                                         Syringe sharing   P value   
  ----------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ----- ----------------- --------- ---------
  Dominant drug usage                                               Opioium                                                                                        Yes   47                23.6%     \<0.001
                                                                                                                                                                                                     
                                                                                                                                                                   No    702               37.1%     
                                                                                                                                                                                                     
                                                                    Amphetamines                                                                                   Yes   12                15.6%     \<0.001
                                                                                                                                                                                                     
                                                                                                                                                                   No    737               36.6%     
                                                                                                                                                                                                     
                                                                    Heroin                                                                                         Yes   331               41.3%     \<0.001
                                                                                                                                                                                                     
                                                                                                                                                                   No    418               32.4%     
                                                                                                                                                                                                     
                                                                    Purified Heroin                                                                                Yes   202               35.9%     0.943
                                                                                                                                                                                                     
                                                                                                                                                                   No    547               35.8%     
                                                                                                                                                                                                     
                                                                    Norjesic                                                                                       Yes   109               35.6%     0.937
                                                                                                                                                                                                     
                                                                                                                                                                   No    640               35.9%     
                                                                                                                                                                                                     
  First place of drug use                                           Own home, home of friends, student home                                                              338               32.1%     0.003
                                                                                                                                                                                                     
                                                                    Roofless public places                                                                               225               40.7%     
                                                                                                                                                                                                     
                                                                    Roofed public places                                                                                 95                36.3%     
                                                                                                                                                                                                     
  First situation of drug use                                       Specific situations(family party, friends party, mourning ceremony, gatherings with friends)         559               35.5%     0.524
                                                                                                                                                                                                     
                                                                    Without Specific situation                                                                           187               37.1%     
                                                                                                                                                                                                     
  What was the most important event that leaded you to first use?   Specific events(work related, familial/domestic, educational)                                        360               38.6%     0.029
                                                                                                                                                                                                     
                                                                    Without Specific event                                                                               376               34%       
                                                                                                                                                                                                     
  Most important reason for beginning drug use                      Pleasure/enjoyment, recreation, Konjkavi                                                             402               34%       0.033
                                                                                                                                                                                                     
                                                                    Without pleasure/enjoyment                                                                           343               38.6%     
                                                                                                                                                                                                     
  First person who suggested you to use substance                   Family or relatives                                                                                  149               42.2%     0.015
                                                                                                                                                                                                     
                                                                    Friends                                                                                              377               35.5%     
                                                                                                                                                                                                     
                                                                    Assistants                                                                                           45                31.5%     
                                                                                                                                                                                                     
                                                                    Others                                                                                               52                29.5%     
                                                                                                                                                                                                     
                                                                    Without mover                                                                                        96                32.0%     

Needle and syringe sharing was lower in those who alone inject (most of times) and home as first place of injection (Table [3](#T3){ref-type="table"}).

###### 

The comparison of syringe sharing between injection-related variables

                                                                                     **Syringe sharinge**           
  ---------------------------------- ----------------------------------------- ----- ---------------------- ------- ---------
  First place of injection           Own home, home of friends, student home         382                    31.6%   0.003
                                                                                                                    
                                     Roofless public places                          206                    41.4%   
                                                                                                                    
                                     Roofed public places                            88                     50%     
                                                                                                                    
  Frequency of injection             Lower than once per day                         145                    31%     0.001
                                                                                                                    
                                     Once and higher per day                         573                    38.2%   
                                                                                                                    
  Site of injection                  Hand                                      No    76                     34.4%   0.639
                                                                                                                    
                                                                               Yes   673                    36.0%   
                                                                                                                    
                                     Foot                                      No    393                    29.9%   \<0.001
                                                                                                                    
                                                                               Yes   356                    45.8%   
                                                                                                                    
                                     Groin                                     No    393                    29.9%   \<0.001
                                                                                                                    
                                                                               Yes   160                    58.4%   
                                                                                                                    
                                     Testis                                    No    575                    32.1%   \<0.001
                                                                                                                    
                                                                               Yes   174                    57.6%   
                                                                                                                    
                                     Neck                                      No    622                    33.4%   \<0.001
                                                                                                                    
                                                                               Yes   127                    56.2%   
                                                                                                                    
                                     Other                                     No    725                    35.6%   0.316
                                                                                                                    
                                                                               Yes   24                     42.1%   
                                                                                                                    
  Cause of first injection           Speed of effect                           No    446                    32.9%   \<0.001
                                                                                                                    
                                                                               Yes   303                    41.2%   
                                                                                                                    
                                     pleasure/enjoyment                        No    404                    30.7%   \<0.001
                                                                                                                    
                                                                               Yes   345                    44.5%   
                                                                                                                    
                                     Effect less of before mode of drug use    No    526                    33.3%   \<0.001
                                                                                                                    
                                                                               Yes   223                    43.6%   
                                                                                                                    
                                     Pry                                       No    589                    35.9%   0.864
                                                                                                                    
                                                                               Yes   160                    35.5%   
                                                                                                                    
                                     Relief of use                             No    573                    35.2%   0.265
                                                                                                                    
                                                                               Yes   176                    38.0%   
                                                                                                                    
                                     Pressure of friends                       No    610                    35.2%   0.208
                                                                                                                    
                                                                               Yes   139                    38.7%   
                                                                                                                    
                                     Substance was not out of reach            No    668                    35.0%   0.007
                                                                                                                    
                                                                               Yes   81                     45.0%   
                                                                                                                    
                                     Low quality of present drugs              No    665                    34.5%   \<0.001
                                                                                                                    
                                                                               Yes   84                     52.2%   
                                                                                                                    
                                     Lower cost of injection                   No    603                    32.7%   \<0.001
                                                                                                                    
                                                                               Yes   146                    59.6%   
                                                                                                                    
                                     Treatment of addiction                    No    736                    36.2%   0.031
                                                                                                                    
                                                                               Yes   13                     22.4%   
                                                                                                                    
  Where do you usually inject?       Own\'s home                               No    375                    39.8%   0.001
                                                                                                                    
                                                                               Yes   374                    32.6%   
                                                                                                                    
                                     Park                                      No    575                    33.3%   \<0.001
                                                                                                                    
                                                                               Yes   174                    48.1%   
                                                                                                                    
                                     School                                    No    743                    35.8%   0.436
                                                                                                                    
                                                                               Yes   6                      46.2%   
                                                                                                                    
                                     Street and lane                           No    554                    32.2%   \<0.001
                                                                                                                    
                                                                               Yes   195                    52.2%   
                                                                                                                    
                                     \"Kharabe\"                               No    385                    26.2%   \<0.001
                                                                                                                    
                                                                               Yes   364                    58.4%   
                                                                                                                    
                                     Student\'s house                          No    740                    35.7%   0.208
                                                                                                                    
                                                                               Yes   9                      50%     
                                                                                                                    
                                     Soldiers\' camp                           No    737                    35.5%   \<0.001
                                                                                                                    
                                                                               Yes   12                     80%     
                                                                                                                    
                                     Prison                                    No    663                    33.5%   \<0.001
                                                                                                                    
                                                                               Yes   86                     76.8%   
                                                                                                                    
                                     Work place                                No    661                    35.5%   0.44
                                                                                                                    
                                                                               Yes   88                     38.1%   
                                                                                                                    
                                     Friend\'s home                            No    473                    34.6%   0.096
                                                                                                                    
                                                                               Yes   276                    38.2%   
                                                                                                                    
  With whom do you usually inject?   Alone                                           493                    33.0%   \<0.001
                                                                                                                    
                                     With others(friends, relatives)                 256                    43.0%   

### High risk behaviors

Lifetime needle and syringe sharing was significantly higher in those IDU who reported extramarital sexual relation) 480,64.1% vs. 269,35.9%; p \< 0.001), history of being arrested by police in the past year(507,67.7% vs. 242,32.3%; p \< 0.001) and history of imprisonment in the past year(455,60.7% vs. 294,39.3%; p \< 0.001).

### Logistic regression

Multivariate logistic regression showed that the likelihood of lifetime needle and syringe sharing was increased by female gender(OR = 2.68, 95%CI = 1.25--5.72, p = 0.01), being jobless (OR = 1.87, 95%CI = 1.41,2.47, p = 0.001), having illegal income (OR = 1.61, 95%CI = 1.21--2.15, p \< 0.001), drug use by family members (OR = 1.47, 95%CI = 1.12--1.92, p = 0.005), first drug use in roofless public place (Odds Ratio = 1.55, 95%CI = 1.15--2.09, p = 0.003), first drug use in roofed public place (Odds Ratio = 1.62, 95%CI = 1.08--2.42, p = 0.01), pleasure/enjoyment as causes of first injection (OR = 1.58, 95%CI = 1.2--2.07, p = 0.001), usual injection at groin(OR = 1.64, 95%CI = 1.11--2.42, p = 0.01), usual injection at scrotum (OR = 1.57, 95%CI = 1.06--2.31, p = 0.02), lifetime experience of nonfatal overdose (OR = 1.68, 95%CI = 1.28--2.21, p \< 0.001), and history of arrest in past year (OR = 1.38, 95%CI = 1.04--1.82, p = 0.02) and was decreased by being alone at most injections (OR = 0.51, 95%CI = 0.38--0.68, p \< 0.001). (Table [4](#T4){ref-type="table"}).

###### 

Logestic regression for having syringe sharing between socio-demographic, drug use and injection-related variables in intravenous drug users (IDUs)

                                                                      **95% Confidence Interval for odds**   
  -------------------------------------------------- -------- ------- -------------------------------------- -------
  Gender(female)                                                      1.259                                  5.725
                                                                                                             
  Jobless                                            \<.001   1.870   1.412                                  2.478
                                                                                                             
  Illegal Income                                     .001     1.617   1.217                                  2.150
                                                                                                             
  Substance use of family members                    .005     1.471   1.125                                  1.925
                                                                                                             
  pleasure/enjoyment as cause of first injection     .001     1.583   1.209                                  2.074
                                                                                                             
  First place of drug use (Roofless public places)   .003     1.558   1.157                                  2.097
                                                                                                             
  First place of drug use (Roofed public places)     .019     1.621   1.084                                  2.424
                                                                                                             
  Alone injection                                    \<.001   .515    .388                                   .682
                                                                                                             
  Groin injection                                    .013     1.642   1.111                                  2.427
                                                                                                             
  Testis injection                                   .022     1.573   1.068                                  2.318
                                                                                                             
  Nonfatal overdose                                  \<.001   1.686   1.282                                  2.216
                                                                                                             
  Arresting in past year                             .022     1.385   1.049                                  1.829

Discussion
==========

In Iran, 1 of 3 IDUs report the history of lifetime needle and syringe sharing. The likelihood of lifetime needle and syringe sharing was increased by female gender, being jobless, having illegal income, drug use by family members, pleasure/enjoyment as causes of first injection, first injection in roofless and roofed public places, usual injection at groin, usual injection at scrotum, lifetime experience of nonfatal overdose, and history of arrest in past year and was decreased by being alone at most injections.

Regarding the literature on syring sharing, according to a study in Mexico, 2005, 80% of the IDUs reported that they share syringes regularly with other IDUs \[[@B18]\]. In another study in Canada 27.6% of the participants reported sharing needles during the past 6 months \[[@B12]\].

Our study showed that needle and syringe sharing was increased in female IDUs. In line with our finding, one study of gender effect on needle and syringe sharing bahavior of IDUs showed that females were more likely to share injecting equipment \[[@B19]-[@B21]\]. A recently qualitative study of Iranian female IDUs reported sharing syringes as a typical behavior \[[@B8]\]. Different risk profile of HIV among male and female IDUs is in line with these reports \[[@B22]\]. So, gender should be addressed as an important variable in needle exchange programs \[[@B23]\].

In our study, jobless IDUs and those who had illegal income had higher rate of needle and syringe sharing. Review of literature shows a link between unemployment of IDUs and needle and syringe sharing behavior \[[@B24],[@B25]\]. Similarly, syringe has been reported to be linked to not having a legal income \[[@B26]\] or engaging in illegal jobs \[[@B27]\]. These may be due to the financial strains to buy stril syrings, and free syrings should be given to these IDUs.

In our study, drug injectors with drug user family members were at higherrisk for needle and syringe sharing. Needle and syringe sharing is reported to be higher in IDUs with a familial network for drug use \[[@B28]\]. Oe study reported that the role of family network on the needle-sharing behavior is more severe in women in comparison with men \[[@B29]\].

In our study, first drug use at public places was linked to more syringe sharering. According to the literature, IDUs who usually inject in public places have oppurtunity for needle and syringe sharing \[[@B30],[@B31]\]. A qualitative study in Iran also confirms this association \[[@B8]\].

Alone injection in compare to injection with someone else, is linked to the lack of oppurtiunity of needle and syringe sharing. In one study in US, markedly lower rates of needle and syringe sharing was observed in IDUs who injecting alone \[[@B32]\]. Injection in the context of social and familial networks is known to be associated with higher needle and syringe sharing \[[@B28]\]. Those who try to keep their injecting hidden, may benefit of a reduced risk of syring sharing \[[@B32]\].

We found that injection in groin and linked to higher needle and syringe sharing in IDUs. However we did not find any study in this regard, studies of bodily injection sites of IDUs have reported a clear progression in sites used, from the upper extrimities, at initial injection to the use of sites such as the groin and scrotum the years after \[[@B33],[@B34]\]. Unjection in sites such as the groin and scrotum were linked to a greater number of injection-related problems. One study showed a link between more severe drug injecting and share needles \[[@B25]\].

We found a link between needle and syringe sharing and nonfatal overdose, which are both high risk behaviors. One study in USA showed that overdosing may be associated with borrowing syringes \[[@B35]\] but in another study in England in1994 to 1995 self-reported overdose was not linked to syring sharing \[[@B36]\]. We also found arrest in the past year as a associated factor with needle and syringe sharing. Similar results have been reported by two studies in Pakistan and Australia \[[@B37],[@B38]\]. Other Risk Behavior Surveys have shown a Co-occurrence of health-risk behaviors among differerent populations \[[@B39],[@B40]\]. These studies have explained their findings with the gateway theory.

In Iran, evidences show that access to a needle and syringe program (NSP) will reduce the needle and needle and syringe sharing practices. The authors suggested NSPs to be intensified in settings with concentrated HIV epidemics among IDUs in Iran \[[@B13]\].

There are some limitations to this study. First, this study is one of a series of secondary analyses \[[@B41]\] and we did not have data on detail of needle and syringe sharing behaviors. Second, the results rely on participants\' self-report data, because self-reports are affected by response bias. Respondents may tend to deny or underreport their syring sharing due to social disirability \[[@B41]\]. Third, because of the cross-sectional design of this study, it is not possible to draw a conclusion on the direction of the associations. Endly, in this study we asked lifetime syring sharing, and we did not limit it by asking sharing during past year or last injection.

Conclusion
==========

In designing interventions for HIV prevention in Iran, through decrease of needle and syringe sharing among IDUs, the introduced variables must be considered. Further studies in this regard are needed.
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